AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets

Abstract Human infections with avian H7N9 subtype influenza viruses are a major public health concern and vaccines against H7N9 are urgently needed for pandemic preparedness. In early 2013, novel H7N9 influenza viruses emerged in China that caused about 1600 human cases of infection with a high asso...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniel Stadlbauer, Leon de Waal, Edith Beaulieu, Shirin Strohmeier, Edwin J. B. Veldhuis Kroeze, Philippe Boutet, Albert D. M. E. Osterhaus, Florian Krammer, Bruce L. Innis, Raffael Nachbagauer, Koert J. Stittelaar, Corey P. Mallett
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/1f961e1904734a6b881c4f9a5ecc6653
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1f961e1904734a6b881c4f9a5ecc6653
record_format dspace
spelling oai:doaj.org-article:1f961e1904734a6b881c4f9a5ecc66532021-12-02T13:17:48ZAS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets10.1038/s41541-021-00299-32059-0105https://doaj.org/article/1f961e1904734a6b881c4f9a5ecc66532021-03-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00299-3https://doaj.org/toc/2059-0105Abstract Human infections with avian H7N9 subtype influenza viruses are a major public health concern and vaccines against H7N9 are urgently needed for pandemic preparedness. In early 2013, novel H7N9 influenza viruses emerged in China that caused about 1600 human cases of infection with a high associated case fatality rate. In this study, two H7N9 split virion vaccines with or without AS03 adjuvant were tested in the naive ferret model. Serological analyses demonstrated that homologous hemagglutination inhibition and microneutralization antibody titers were detectable in the ferrets after the first immunization with the AS03-adjuvanted vaccines that were further boosted by the second immunization. In addition, heterologous antibody titers against older H7 subtype viruses of the North American lineage (H7N7, H7N3) and newer H7 subtype viruses of the Eurasian lineage (H7N9) were detected in the animals receiving the AS03-adjuvanted vaccines. Animals receiving two immunizations of the AS03-adjuvanted vaccines were protected from weight loss and fever in the homologous challenge study and had no detectable virus in throat or lung samples. In addition, microscopic examination post-challenge showed animals immunized with the AS03-adjuvanted vaccines had the least signs of lung injury and inflammation, consistent with the greater relative efficacy of the adjuvanted vaccines. In conclusion, this study demonstrated that the AS03-adjuvanted H7N9 vaccines elicited high levels of homologous and heterologous antibodies and protected against H7N9 virus damage post-challenge.Daniel StadlbauerLeon de WaalEdith BeaulieuShirin StrohmeierEdwin J. B. Veldhuis KroezePhilippe BoutetAlbert D. M. E. OsterhausFlorian KrammerBruce L. InnisRaffael NachbagauerKoert J. StittelaarCorey P. MallettNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Daniel Stadlbauer
Leon de Waal
Edith Beaulieu
Shirin Strohmeier
Edwin J. B. Veldhuis Kroeze
Philippe Boutet
Albert D. M. E. Osterhaus
Florian Krammer
Bruce L. Innis
Raffael Nachbagauer
Koert J. Stittelaar
Corey P. Mallett
AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets
description Abstract Human infections with avian H7N9 subtype influenza viruses are a major public health concern and vaccines against H7N9 are urgently needed for pandemic preparedness. In early 2013, novel H7N9 influenza viruses emerged in China that caused about 1600 human cases of infection with a high associated case fatality rate. In this study, two H7N9 split virion vaccines with or without AS03 adjuvant were tested in the naive ferret model. Serological analyses demonstrated that homologous hemagglutination inhibition and microneutralization antibody titers were detectable in the ferrets after the first immunization with the AS03-adjuvanted vaccines that were further boosted by the second immunization. In addition, heterologous antibody titers against older H7 subtype viruses of the North American lineage (H7N7, H7N3) and newer H7 subtype viruses of the Eurasian lineage (H7N9) were detected in the animals receiving the AS03-adjuvanted vaccines. Animals receiving two immunizations of the AS03-adjuvanted vaccines were protected from weight loss and fever in the homologous challenge study and had no detectable virus in throat or lung samples. In addition, microscopic examination post-challenge showed animals immunized with the AS03-adjuvanted vaccines had the least signs of lung injury and inflammation, consistent with the greater relative efficacy of the adjuvanted vaccines. In conclusion, this study demonstrated that the AS03-adjuvanted H7N9 vaccines elicited high levels of homologous and heterologous antibodies and protected against H7N9 virus damage post-challenge.
format article
author Daniel Stadlbauer
Leon de Waal
Edith Beaulieu
Shirin Strohmeier
Edwin J. B. Veldhuis Kroeze
Philippe Boutet
Albert D. M. E. Osterhaus
Florian Krammer
Bruce L. Innis
Raffael Nachbagauer
Koert J. Stittelaar
Corey P. Mallett
author_facet Daniel Stadlbauer
Leon de Waal
Edith Beaulieu
Shirin Strohmeier
Edwin J. B. Veldhuis Kroeze
Philippe Boutet
Albert D. M. E. Osterhaus
Florian Krammer
Bruce L. Innis
Raffael Nachbagauer
Koert J. Stittelaar
Corey P. Mallett
author_sort Daniel Stadlbauer
title AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets
title_short AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets
title_full AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets
title_fullStr AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets
title_full_unstemmed AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets
title_sort as03-adjuvanted h7n9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1f961e1904734a6b881c4f9a5ecc6653
work_keys_str_mv AT danielstadlbauer as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
AT leondewaal as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
AT edithbeaulieu as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
AT shirinstrohmeier as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
AT edwinjbveldhuiskroeze as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
AT philippeboutet as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
AT albertdmeosterhaus as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
AT floriankrammer as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
AT brucelinnis as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
AT raffaelnachbagauer as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
AT koertjstittelaar as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
AT coreypmallett as03adjuvantedh7n9inactivatedsplitvirionvaccinesinducecrossreactiveandprotectiveresponsesinferrets
_version_ 1718393320267317248